Location: Home
  • search
  • go
  • Relate News
  • 8/5/2021Hanmi Pharma and Lego Chem Bio Enter Partnership Deal to Co-develop AD...
  • 8/5/2021Promega and Henlius Developing MSI Companion Diagnostic IVD Kit for Se...
  • 8/5/2021Review of China Healthcare Sector Performance in H1/2021
  • 8/5/2021Forbes: Bayer Sees A Golden Age For China's Pharmaceutical Market
  • 8/5/2021China Is Poised To Enter The Global Injectable Market – An Expert CDM...
  • 8/4/2021NMPA Reportedly Seeking Comments on Proposed Regulation of Online Drug...
  • 8/3/2021Burning Rock and IMPACT Therapeutics Announce a Global Partnership for...
  • 8/3/2021WuXi STA Completes Acquisition of BMS Manufacturing Facility in Couvet...
  • 8/2/2021SMEI: Chinese Retail Pharmacy Market (Offline and Online) Rose 12.5% i...
  • 8/2/2021SMEI Predicts Restructure of Chinese Drug Retail Market and Further Bo...
  • 8/2/2021Eisai's Anti-Epileptic Fycompa Approved in China as Monotherapy for Pa...
  • 8/2/2021WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Cert...
  • 8/2/2021Chinese Biosimilars Surge between 2018 and 2020 Due to New NMPA Regula...
  • 8/2/2021Biopharma Companies Still Waiting for Clarity on China's New Patent Te...
  • 8/1/2021NHSA Publicizes the List of Drugs Passing Form Evaluation for Inclusio...
  • 7/30/2021Financial-related Company News in Brief (July 2021)
  • 7/30/2021Recent Executive Moves
  • 7/29/2021SMEI: Chinese Drug Market under Transformation with Growing ex-Hospita...
  • 7/29/2021Junshi's Chinese sNDA for Toripalimab Plus Chemotherapy as First-Lin...
  • 7/29/2021Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D a...
  • 7/29/2021Complix Signs Global Drug R&D Pact with Nhwa Pharma to Develop Novel A...
  • 7/29/2021I-Mab's Chinese IND for P2 Trial of Efineptakin Alfa in Combo with PD-...
  • 7/29/2021Health Care in the Year of the Ox: Navigating China's Dynamic M&A Mark...
  • 7/28/2021NHC Issues the Guidelines for Comprehensive Clinical Appraisal of Drug...
  • 7/28/2021Daewoong Reports Positive Chinese Ph3 Trial Outcome of Its Botulinum...
  • 7/27/2021NMPA Revises Packages Insert of Vitamin B6 Injection
  • 7/27/2021NMPA Issues the Announcement on Certain Matters Related to Drug-Device...
  • 7/27/2021HUTCHMED and AZ Initiate Phase II Trial of ORPATHYS for MET Amplified ...
  • 7/27/2021NASDAQ-listed I-Mab to Seek Dual Listing on Shanghai's STAR Market
  • 7/27/2021Sanofi Secures A New Indication for Renvela (sevelamer) in China
  • Page:95/367 Total number of articles:10986: [First][<<] [93] [94] [95] [96] [97] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group